drugset / Trial / NCT07811895
Dual GIP/GLP-1 Receptor Agonist in Obese Women Before Frozen Embryo Transfer
Not yet recruiting
1510 enrolled
RenJi Hospital
Anhui Provincial Hospital · collabHenan Provincial People's Hospital · collabJiangsu Provincial People's Hospital · collabNanjing Maternity and Child Health Care Hospital · collabNingbo Women & Children's Hospital · collabNorthwest Women's and Children's Hospital, Xi'an, Shaanxi · collabShandong University · collabShanghai First Maternity and Infant Hospital · collabShanghai Zhongshan Hospital · collabShenyang Jinghua Hospital · collabShenyang Women's and Children's Hospital · collabThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School · collabThe First Affiliated Hospital of Anhui Medical University · collabThe First Affiliated Hospital of Zhengzhou University · collabThe Second Hospital of Hebei Medical University · collabThird Affiliated Hospital of Zhengzhou University · collabTianjin Central Hospital of Gynecology Obstetrics · collabTongji Hospital · collabWest China Second University Hospital · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
To evaluate the efficacy and safety of Dual GIP/GLP-1 receptor agonist pretreatment on reproductive outcomes in obese women before frozen embryo transfer.
Timeline
- Start
- 2026-09
- Primary completion
- 2029-12
- Completion
- 2030-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tirzepatide | Peptide | — | — |